-
Article
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia
Therapy-related myelodysplasia (MDS) is a fatal marrow disorder distinct from primary MDS. We examined the efficacy of bone marrow transplantation (BMT) as a treatment for patients with therapy-related MDS. Ei...
-
Article
Successful autologous bone marrow transplant without the use of blood product support
We describe a successful autologous bone marrow transplant without the use of any blood products. The patient had relapsed large cell lymphoma. He was a Jehovah's Witness and would not accept transfusions of r...
-
Article
Response to Sefcick et al
-
Article
Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units
Umbilical cord blood (CB) is a useful stem cell source for patients without matched family donors. CB banking is expensive, however, because only a small percentage of the cord units stored are used for transp...
-
Article
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
Although patients with relapsed Hodgkin's disease have a poor prognosis with conventional therapies, high-dose chemotherapy and autologous hematopoietic stem cell transplantation (autotransplantation) may prov...
-
Article
Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support
Considerable progress has been made in improving the control of chemotherapy-induced emesis. The impact of available antiemetic options for patients receiving stem cell transplants is unclear, as few prospecti...
